Article Text
PostScript
Correspondence
Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisis
Statistics from Altmetric.com
Footnotes
Handling editor Mary Frances McMullin
Contributors SEL performed laboratory studies. CMC, JQ and PTM provided patient care and clinical information. All authors contributed to manuscript preparation and approved the submitted version.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.